Laboratory Diagnostics

Please log in to buy

Genomic Insight


Experience the difference of AI-powered DNA testing with GenomicInsight™.

GenomicInsight™ reports on over 5,000 single nucleotide polymorphisms (SNPs) in one comprehensive functional DNA test, without costly 'add-on' panels.

Powered by Opus23 Explorer™, this profile uses the most advanced artificial intelligence to give clinicians a unique insight into patient genomics. 

The reports are customisable; you can choose what profiles you'd like reporting on. You/your patient will have the option to select as many, or as few, profiles at the time of taking the test.

Profiles available:

  • detoxification
  • methylation
  • cognition
  • inflammation
  • anti-ageing
  • endocrine
  • endocrine - oestrogen metabolism
  • endocrine - androgen metabolism
  • structural
  • energy metabolism
  • cardio-metabolic

The profiles evaluate over 12 key functional areas of health, including but not limited to:

  • detoxification
  • methylation
  • metabolic syndrome
  • pharmacogenomics
  • oestrogen metabolism
  • ageing
  • cardiovascular health
  • HPA-axis
  • mitochondrial health
  • nutrigenomics
  • sex hormones
  • autoimmunity 

If you decide you'd like to receive a profile(s) at a later date that you didn't initially select for reporting, we just charge a £35.00 fee to have these reported.

The results include therapeutic recommendations backed by the latest medical literature from PubMed, GWAS (genome wide association study), dbSNP, HapMap (haplotype map) and several others.

This includes relevant information on nutraceuticals, nutritional supplements, diet, and lifestyle interventions that can proactively influence a patient’s SNPs to reduce or prevent disease risk. Furthermore, pharmacogenomic results included in the profile allow practitioners to predict the efficacy of select pharmaceuticals tailored the individual’s genetic make-up.

PLEASE NOTE: we do not offer clinical consults on this test.

Sample Type
Buccal swab
Turnaround time

3-4 weeks.

Additional Information / Instructions

Instructions (coming soon)

Diagnostic Solutions Laboratory does not share any patient data with third parties for commercial use. Additionally, we will never disclose or share your Genetic Information or Self-Reported Health Status with insurance companies or employers.

The Genetic Information NonDiscrimination Act (GINA) was enacted in 2008 and protects you from being discriminated against by employers and health insurance companies as a result of your genetics. The GINA Act was created to protect your genetic health information, and to allow patients access to protected, personalised medicine.

Unless required by law, we will never release your genetic information or your Self-Reported Health Status to anyone without your obtaining your explicit consent.

Sample Reports / Downloads